Sanofi has entered exclusive talks with US private equity company Clayton Dubilier & Rice (CD&R) over the sale of the ...

Under the proposed deal, CD&R would acquire a 50% controlling interest in Opella, while Sanofi would retain a substantial ...

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake ...

Sanofi, which ranks 297th on the Fortune Global 500, recently announced it would sell a 50% stake of its consumer healthcare business Opella in an effort to focus primarily on innovation within ...

Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French government seeks to ...

Hi, it’s Aaron Kirchfeld, Pamela Barbaglia, Dinesh Nair and Swetha Gopinath in London, looking at how Europe's biggest buyout deal became a bruising brawl. Also today, Southwest avoids a proxy ...

(RTTNews) - Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R.

PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year. The French ...

Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised ...

Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised financial statements for Sanofi ...

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% ...